Global T Cell Specific Surface Glycoprotein CD28 Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of T Cell Specific Surface Glycoprotein CD28
- 1.1 Definition of T Cell Specific Surface Glycoprotein CD28
- 1.2 T Cell Specific Surface Glycoprotein CD28 Segment by Type
- 1.2.1 Global T Cell Specific Surface Glycoprotein CD28 Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 FPT-155
- 1.2.3 FR-104
- 1.2.4 Lulizumab Pegol
- 1.2.5 Others
- 1.3 T Cell Specific Surface Glycoprotein CD28 Segment by Applications
- 1.3.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption Comparison by Applications (2014-2025)
- 1.3.2 Plaque Psoriasis
- 1.3.3 Solid Tumor
- 1.3.4 Acute Renal Failure(ARF)
- 1.3.5 Others
- 1.4 Global T Cell Specific Surface Glycoprotein CD28 Overall Market
- 1.4.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue (2014-2025)
- 1.4.2 Global T Cell Specific Surface Glycoprotein CD28 Production (2014-2025)
- 1.4.3 North America T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
- 1.4.4 Europe T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
- 1.4.5 China T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
- 1.4.6 Japan T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
- 1.4.8 India T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of T Cell Specific Surface Glycoprotein CD28
- 2.3 Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28
- 2.4 Industry Chain Structure of T Cell Specific Surface Glycoprotein CD28
3 Development and Manufacturing Plants Analysis of T Cell Specific Surface Glycoprotein CD28
- 3.1 Capacity and Commercial Production Date
- 3.2 Global T Cell Specific Surface Glycoprotein CD28 Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of T Cell Specific Surface Glycoprotein CD28
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 T Cell Specific Surface Glycoprotein CD28 Production and Capacity Analysis
- 4.2 T Cell Specific Surface Glycoprotein CD28 Revenue Analysis
- 4.3 T Cell Specific Surface Glycoprotein CD28 Price Analysis
- 4.4 Market Concentration Degree
5 T Cell Specific Surface Glycoprotein CD28 Regional Market Analysis
- 5.1 T Cell Specific Surface Glycoprotein CD28 Production by Regions
- 5.1.1 Global T Cell Specific Surface Glycoprotein CD28 Production by Regions
- 5.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Regions
- 5.2 T Cell Specific Surface Glycoprotein CD28 Consumption by Regions
- 5.3 North America T Cell Specific Surface Glycoprotein CD28 Market Analysis
- 5.3.1 North America T Cell Specific Surface Glycoprotein CD28 Production
- 5.3.2 North America T Cell Specific Surface Glycoprotein CD28 Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America T Cell Specific Surface Glycoprotein CD28 Import and Export
- 5.4 Europe T Cell Specific Surface Glycoprotein CD28 Market Analysis
- 5.4.1 Europe T Cell Specific Surface Glycoprotein CD28 Production
- 5.4.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe T Cell Specific Surface Glycoprotein CD28 Import and Export
- 5.5 China T Cell Specific Surface Glycoprotein CD28 Market Analysis
- 5.5.1 China T Cell Specific Surface Glycoprotein CD28 Production
- 5.5.2 China T Cell Specific Surface Glycoprotein CD28 Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China T Cell Specific Surface Glycoprotein CD28 Import and Export
- 5.6 Japan T Cell Specific Surface Glycoprotein CD28 Market Analysis
- 5.6.1 Japan T Cell Specific Surface Glycoprotein CD28 Production
- 5.6.2 Japan T Cell Specific Surface Glycoprotein CD28 Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan T Cell Specific Surface Glycoprotein CD28 Import and Export
- 5.7 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Market Analysis
- 5.7.1 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Production
- 5.7.2 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Import and Export
- 5.8 India T Cell Specific Surface Glycoprotein CD28 Market Analysis
- 5.8.1 India T Cell Specific Surface Glycoprotein CD28 Production
- 5.8.2 India T Cell Specific Surface Glycoprotein CD28 Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India T Cell Specific Surface Glycoprotein CD28 Import and Export
6 T Cell Specific Surface Glycoprotein CD28 Segment Market Analysis (by Type)
- 6.1 Global T Cell Specific Surface Glycoprotein CD28 Production by Type
- 6.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type
- 6.3 T Cell Specific Surface Glycoprotein CD28 Price by Type
7 T Cell Specific Surface Glycoprotein CD28 Segment Market Analysis (by Application)
- 7.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption by Application
- 7.2 Global T Cell Specific Surface Glycoprotein CD28 Consumption Market Share by Application (2014-2019)
8 T Cell Specific Surface Glycoprotein CD28 Major Manufacturers Analysis
- 8.1 Atox Bio Ltd
- 8.1.1 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
- 8.1.2 Atox Bio Ltd Product Introduction, Application and Specification
- 8.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Bristol-Myers Squibb Co
- 8.2.1 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
- 8.2.2 Bristol-Myers Squibb Co Product Introduction, Application and Specification
- 8.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Five Prime Therapeutics Inc
- 8.3.1 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
- 8.3.2 Five Prime Therapeutics Inc Product Introduction, Application and Specification
- 8.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Johnson & Johnson
- 8.4.1 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
- 8.4.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 TheraMAB LLC
- 8.5.1 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
- 8.5.2 TheraMAB LLC Product Introduction, Application and Specification
- 8.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
9 Development Trend of Analysis of T Cell Specific Surface Glycoprotein CD28 Market
- 9.1 Global T Cell Specific Surface Glycoprotein CD28 Market Trend Analysis
- 9.1.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size (Volume and Value) Forecast 2019-2025
- 9.2 T Cell Specific Surface Glycoprotein CD28 Regional Market Trend
- 9.2.1 North America T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
- 9.2.2 Europe T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
- 9.2.3 China T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
- 9.2.4 Japan T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
- 9.2.5 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
- 9.2.6 India T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
- 9.3 T Cell Specific Surface Glycoprotein CD28 Market Trend (Product Type)
- 9.4 T Cell Specific Surface Glycoprotein CD28 Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 T Cell Specific Surface Glycoprotein CD28 Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global T Cell Specific Surface Glycoprotein CD28 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on T Cell Specific Surface Glycoprotein CD28 volume and value at global level, regional level and company level. From a global perspective, this report represents overall T Cell Specific Surface Glycoprotein CD28 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of T Cell Specific Surface Glycoprotein CD28 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their T Cell Specific Surface Glycoprotein CD28 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Atox Bio Ltd
Bristol-Myers Squibb Co
Five Prime Therapeutics Inc
Johnson & Johnson
TheraMAB LLC
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
FPT-155
FR-104
Lulizumab Pegol
Others
Segment by Application
Plaque Psoriasis
Solid Tumor
Acute Renal Failure(ARF)
Others